MA45768A - Procédé pour la préparation de compositions d'immunoglobulines - Google Patents

Procédé pour la préparation de compositions d'immunoglobulines

Info

Publication number
MA45768A
MA45768A MA045768A MA45768A MA45768A MA 45768 A MA45768 A MA 45768A MA 045768 A MA045768 A MA 045768A MA 45768 A MA45768 A MA 45768A MA 45768 A MA45768 A MA 45768A
Authority
MA
Morocco
Prior art keywords
preparation
immunoglobulin compositions
immunoglobulin
compositions
Prior art date
Application number
MA045768A
Other languages
English (en)
Inventor
Achim Hannappel
Oliver Maneg
Alexander Möhlenkamp-Röttger
Wolfgang Möller
Dieter Rudnick
Original Assignee
Biotest Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotest Ag filed Critical Biotest Ag
Publication of MA45768A publication Critical patent/MA45768A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
MA045768A 2016-07-27 2017-07-26 Procédé pour la préparation de compositions d'immunoglobulines MA45768A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16181493.4A EP3275897A1 (fr) 2016-07-27 2016-07-27 Procédé de préparation de compositions d'immunoglobuline

Publications (1)

Publication Number Publication Date
MA45768A true MA45768A (fr) 2019-06-05

Family

ID=56555240

Family Applications (1)

Application Number Title Priority Date Filing Date
MA045768A MA45768A (fr) 2016-07-27 2017-07-26 Procédé pour la préparation de compositions d'immunoglobulines

Country Status (10)

Country Link
US (2) US11325964B2 (fr)
EP (2) EP3275897A1 (fr)
JP (1) JP7073333B2 (fr)
CN (1) CN109641950B (fr)
AU (1) AU2017302006B2 (fr)
BR (1) BR112019000736A2 (fr)
CA (1) CA3031462A1 (fr)
EA (1) EA201990392A1 (fr)
MA (1) MA45768A (fr)
WO (1) WO2018019898A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2877589B1 (fr) 2012-07-26 2024-03-06 Momenta Pharmaceuticals, Inc. Glycoprotéines ayant des propriétés anti-inflammatoires
WO2014186310A1 (fr) 2013-05-13 2014-11-20 Momenta Pharmaceuticals, Inc. Méthodes de traitement de la neurodégénérescence
WO2015057622A1 (fr) 2013-10-16 2015-04-23 Momenta Pharmaceuticals, Inc. Glycoprotéines sialylées
CN109575129B (zh) * 2018-12-29 2022-04-26 贵州泰邦生物制品有限公司 一种静注人免疫球蛋白的制备工艺
US11732004B2 (en) * 2020-04-10 2023-08-22 Plasma Technologies, Llc Compositions and methods for simplified high efficiency isolation of proteins
US11884702B2 (en) * 2020-12-28 2024-01-30 Plasma Technologies, Llc Systems and methods for process scale isolation of immunoglobulin G
CA3223881A1 (fr) * 2021-07-29 2023-02-02 Roopsee ANAND Procede de purification d'immunoglobuline g et ses utilisations
AU2024380406A1 (en) 2023-11-15 2026-04-16 Biotest Ag Method of manufacturing an igm containing composition

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136094A (en) 1977-08-31 1979-01-23 The Regents Of The University Of Minnesota Preparation of intravenous human and animal gamma globulins and isolation of albumin
US4296027A (en) 1977-08-31 1981-10-20 The Regents Of The University Of Minnesota Pure intravenous human and animal gamma globulins
DE2901822A1 (de) 1979-01-18 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung einer fuer die intravenoese applikation geeigneten immunglobulinloesung, die igm in ankonzentrierter form enthaelt
SU1137098A1 (ru) * 1983-07-21 1985-01-30 Московская ветеринарная академия им.К.И.Скрябина Способ выделени пропердина из сыворотки крови
IL90281A (en) 1988-06-06 1994-10-07 Miles Inc Preparations containing MGI antibodies
DE3825429C2 (de) 1988-07-27 1994-02-10 Biotest Pharma Gmbh Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt
DE3927112C1 (fr) 1989-08-17 1990-10-25 Biotest Pharma Gmbh, 6072 Dreieich, De
DE3927111C3 (de) 1989-08-17 1994-09-01 Biotest Pharma Gmbh Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate
ES2074490T5 (es) 1990-03-22 2004-02-16 Biotest Pharma Gmbh Procedimiento para la elaboracion de un preparado de inmunoglobulina g tolerable por via intravenosa.
US5256771A (en) 1990-04-03 1993-10-26 Miles Inc. Heat treatment of IgM-containing immunoglobulins to eliminate non-specific complement activation
FI952196A0 (fi) 1995-05-08 1995-05-08 Suomen Punainen Risti Veripalv Framstaellning av immunoglobulin
TW491855B (en) 1996-08-07 2002-06-21 Csl Ltd Purification of immunoglobulins
NZ503033A (en) 1997-08-26 2003-01-31 Gliatech Inc Inhibition of complement activation using anti-properdin agents
US5854051A (en) 1997-09-15 1998-12-29 Heska Corporation Parasitic helminth asparaginase proteins, nucleic acid molecules, and uses thereof
DK2270044T3 (en) * 1998-06-09 2015-01-26 Csl Behring Ag Liquid immunoglobulin G (IgG) product
IL140155A (en) * 1998-06-09 2005-12-18 Statens Seruminstitut Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
FR2824568B1 (fr) 2001-05-11 2004-04-09 Lab Francais Du Fractionnement Procede de preparation de concentres d'immunoglobulines humaines a usage therapeutique
US6593744B2 (en) 2001-11-20 2003-07-15 Koninklijke Philips Electronics, N.V. Multi-channel RF cable trap for magnetic resonance apparatus
TWI445714B (zh) 2009-05-27 2014-07-21 Baxter Int 產製用於皮下使用之高濃度免疫球蛋白製備物之方法
IT1397061B1 (it) 2009-12-28 2012-12-28 Kedrion Spa Nuovo processo di purificazione su scala industriale di gammaglobuline da plasma umano per uso industriale.
GB201006753D0 (en) 2010-04-22 2010-06-09 Biotest Ag Process for preparing an immunolobulin composition
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
IL212911A0 (en) * 2011-05-16 2011-07-31 Omrix Biopharmaceuticals Ltd Immunoglobulin reduced in thrombogenic contaminants and preparation thereof
KR20140064768A (ko) * 2011-07-01 2014-05-28 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 항-프로퍼딘 항체 및 그의 용도
SG11201400233TA (en) * 2011-08-26 2014-08-28 Baxter Int Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition
SG10201701224UA (en) * 2012-03-12 2017-04-27 Merck Patent Gmbh Removal of protein aggregates from biopharmaceutical preparations in a flowthrough mode
AU2013203043B2 (en) 2013-03-15 2016-10-06 Takeda Pharmaceutical Company Limited Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs
US10144774B2 (en) * 2013-07-01 2018-12-04 Csl Behring Ag Method for purifying IgG
FR3018450B1 (fr) 2014-03-11 2016-04-15 Lab Francais Du Fractionnement Procede de preparation de proteines plasmatiques humaines
KR101917197B1 (ko) * 2014-03-11 2018-11-09 주식회사 녹십자홀딩스 면역글로불린의 정제방법
CN104402993B (zh) * 2014-11-28 2017-01-04 贵州泰邦生物制品有限公司 一种制备静注人免疫球蛋白的方法

Also Published As

Publication number Publication date
CA3031462A1 (fr) 2018-02-01
US20190161533A1 (en) 2019-05-30
CN109641950B (zh) 2023-06-02
AU2017302006A1 (en) 2019-01-24
EP3275897A1 (fr) 2018-01-31
WO2018019898A1 (fr) 2018-02-01
US11325964B2 (en) 2022-05-10
AU2017302006B2 (en) 2024-07-25
EP3491018A1 (fr) 2019-06-05
EA201990392A1 (ru) 2019-07-31
US20220227841A1 (en) 2022-07-21
JP7073333B2 (ja) 2022-05-23
CN109641950A (zh) 2019-04-16
BR112019000736A2 (pt) 2019-05-07
JP2019525933A (ja) 2019-09-12

Similar Documents

Publication Publication Date Title
MA45768A (fr) Procédé pour la préparation de compositions d'immunoglobulines
EP3448918A4 (fr) Procédé de préparation de résines d'organopolysiloxane
EP3315512A4 (fr) Procédé pour la préparation sélective d'un conjugué anticorps-médicament
EP3658552A4 (fr) Procédé amélioré pour la préparation de dérivés d'aminopyrimidine
EP3706725A4 (fr) Processus pour la préparation de tapinarof
EP3683205A4 (fr) Procédé de préparation d'isocyanate aliphatique
EP3504196A4 (fr) Procédés de préparation d'olaparib
EP3372620A4 (fr) Composition de catalyseur pour synthétiser un copolymère d'oléfine et procédé de préparation de copolymère d'oléfine
EP3476478A4 (fr) Composition pour l'élimination de composés soufrés
EP3541379A4 (fr) Compositions pour le traitement de l'hypertension
EP3766869A4 (fr) Procédé simple de préparation d'avibactam
EP3402837A4 (fr) Procédé de préparation de nanocomposite de polyéthylène
EP3733648A4 (fr) Procédé de préparation d'acide 5r-benzyloxyaminopipéridin-2s-carboxylique ou d'un dérivé de celui-ci
EP3431520A4 (fr) Procédé de préparation d'un copolymère d'oxyméthylène
EP3696168A4 (fr) Procédé de préparation de 2-chloro-5-trifluorométhylpyridine
EP3406619A4 (fr) Procédé et intermédiaire pour la préparation de la tulathromycine
EP3511313A4 (fr) Procédé de préparation de 1,3-cyclohexanediméthanol
EP3788027A4 (fr) Procédé à recirculation pour la préparation d'éthylène glycol
MA51870A (fr) Procédé pour la préparation de composés coupleurs de médicaments
EP3902792A4 (fr) Procédé de préparation d'anthranilamides
EP3314001A4 (fr) Procédés et compositions pour la préparation d'éphédrine et de composés alcaloïdes apparentés
EP3453046A4 (fr) Composés glutarate pour le traitement de lésions d'ischémie-reperfusion
EP3533856A4 (fr) Procédé de préparation d'hexadécahydropyrène
EP3681863A4 (fr) Procédé amélioré pour la préparation de trifloxystrobine
EP3666756A4 (fr) Procédé de préparation de lévétiracétam